Eastwood Bio-medical Canada Inc. (TSX-V: EBM) (the “Company”) has engaged NAI Interactive Ltd. (NAI) to conduct a twelve-month market visibility program.
Yunji Kim, President and CEO, stated, “We have always had fantastic products the market craves. For example, Advertising Standards Canada authorized us in 2014 to market Eleotin® Bentley, our flagship product, as the ‘World’s #1 Doctor Recommended Natural Source Healthy Blood Glucose Promoting Product available in Canada.’ We have also won prestigious international awards, and been endorsed by numerous diabetes associations.
But, our limited production capacity prevented us from taking full advantage of this market demand. The recent acquisition of new manufacturing capabilities, however, would finally resolve this issue for us.
With our manufacturing capability problem behind us, and with NAI‟s expertise working for us, we look forward to sharing with a wider audience our rich history and our future development and growth.
We have acquired thirty five new Natural Product Numbers in 2017 and 2018. We will continue to add scientifically researched, new and exciting natural health products.”
For further information, please contact:
Eastwood Bio-medical Canada Inc.
Yunji Kim, President and Chief Executive Officer
Telephone: (604)-247-2100
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
